A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells

Nat Cell Biol. 2018 Jan;20(1):21-27. doi: 10.1038/s41556-017-0002-2. Epub 2017 Dec 11.

Abstract

CD8+ memory T (Tm) cells are fundamental for protective immunity against infections and cancers 1-5 . Metabolic activities are crucial in controlling memory T-cell homeostasis, but mechanisms linking metabolic signals to memory formation and survival remain elusive. Here we show that CD8+ Tm cells markedly upregulate cytosolic phosphoenolpyruvate carboxykinase (Pck1), the hub molecule regulating glycolysis, tricarboxylic acid cycle and gluconeogenesis, to increase glycogenesis via gluconeogenesis. The resultant glycogen is then channelled to glycogenolysis to generate glucose-6-phosphate and the subsequent pentose phosphate pathway (PPP) that generates abundant NADPH, ensuring high levels of reduced glutathione in Tm cells. Abrogation of Pck1-glycogen-PPP decreases GSH/GSSG ratios and increases levels of reactive oxygen species (ROS), leading to impairment of CD8+ Tm formation and maintenance. Importantly, this metabolic regulatory mechanism could be readily translated into more efficient T-cell immunotherapy in mouse tumour models.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Mercaptopropionic Acid / pharmacology
  • Adoptive Transfer
  • Animals
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / transplantation
  • Citric Acid Cycle / drug effects
  • Citric Acid Cycle / genetics
  • Citric Acid Cycle / immunology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Gluconeogenesis / drug effects
  • Gluconeogenesis / genetics
  • Gluconeogenesis / immunology
  • Glucose / immunology
  • Glucose / metabolism*
  • Glycogen / immunology
  • Glycogen / metabolism*
  • Glycolysis / drug effects
  • Glycolysis / genetics
  • Glycolysis / immunology
  • Homeostasis / immunology
  • Immunologic Memory
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Intracellular Signaling Peptides and Proteins / immunology
  • Melanoma, Experimental / drug therapy
  • Melanoma, Experimental / genetics*
  • Melanoma, Experimental / immunology
  • Melanoma, Experimental / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • NADP / immunology
  • NADP / metabolism
  • Pentose Phosphate Pathway / drug effects
  • Pentose Phosphate Pathway / genetics
  • Pentose Phosphate Pathway / immunology
  • Phosphoenolpyruvate Carboxykinase (GTP) / antagonists & inhibitors
  • Phosphoenolpyruvate Carboxykinase (GTP) / genetics*
  • Phosphoenolpyruvate Carboxykinase (GTP) / immunology
  • Reactive Oxygen Species / immunology
  • Reactive Oxygen Species / metabolism
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / metabolism

Substances

  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Reactive Oxygen Species
  • NADP
  • Glycogen
  • 3-Mercaptopropionic Acid
  • Pck1 protein, mouse
  • Phosphoenolpyruvate Carboxykinase (GTP)
  • Glucose